comparison of glp-1 integrated weight management platforms Comparing GLP‑1 Drugs With Other Loss Methods: Diet & Exercise, Bariatric Surgery, and Lifestyle Programs -Pros & Cons Nutritional priorities to support GLP-1

GLP-1 receptor agonists (GLP-1 RAs)such as Semaglutide (Ozempic, Wegovy) and Tirzepatide (Mounjaro, Zepbound)have traditionally been prescribed for Type 2 diabetes and obesity

The Surging Popularity of GLP-1s By 2024, approximately 4% of Americans were taking a GLP-1 receptor agonist for weight loss, obesity, or type 2 diabetesa staggering 600% increase since 2018

United Healthcare covers Ozempic as a Tier 3 medication under its Essential Drug Plan for treating type 2 diabetes

Ten Kulve JS, Veltman DJ, van Bloemendaal L, Groot PFC, Ruh HG, Barkhof F, et al

(Standard Process emphasizes the food matrix advantage)

This can contribute to: Lower resting metabolic rate Increased risk of weight regain "Skinny fat" body composition Fatigue and weakness Loss of firmness in the face or body The appearance often described as "Ozempic face" or "Ozempic butt" Our program emphasizes: Body Composition Analysis Resting Metabolic Rate Testing Adequate protein intake Resistance training and movement Thoughtful medication dosing Functional medicine lab evaluation Muscle-supportive peptide options when appropriate Initial Consultation & Metabolic Assessment Your program begins with a comprehensive medical consultation with Dr